We have observed
3 EP applications
Matthew William Rodgers
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
TREATMENT OF VASCULAR DISEASES USING ENCAPSULATED CELLS ENCODING AND SECRETING GLP-1, OR A FRAGMENT OR VARIANT THEREOF